Onco-Innovations Limited
ONNVF
$0.46
-$0.01-2.49%
OTC PK
| 04/30/2026 | 01/31/2026 | 10/31/2025 | 07/31/2025 | 04/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -1.08M | -2.24M | -2.60M | -1.93M | -3.30M |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 200.40K | 1.19M | 1.76M | 68.40K | 2.54M |
| Change in Net Operating Assets | 190.50K | 623.40K | -450.60K | 435.50K | -77.90K |
| Cash from Operations | -689.20K | -424.00K | -1.29M | -1.43M | -835.20K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | 5.50K |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | 5.50K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -5.40K |
| Issuance of Common Stock | 1.22M | 500.00 | 2.07M | 1.79M | 884.70K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -10.70K | 0.00 | -130.70K | -- | 0.00 |
| Cash from Financing | 880.60K | 400.00 | 1.40M | 1.30M | 618.60K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 191.40K | -423.60K | 104.70K | -122.60K | -211.00K |